LIAISON® MeMed BV®
Know when to treat with antibiotics.
Accurate and rapid differentiation between bacterial and viral infections equals better patient care.
Tell us who you are
Background
To treat or not to treat with antibiotics? Transform patient care with confidence while empowering antimicrobial stewardship
Increased antimicrobial resistance is one of the key healthcare challenges around the world. It is largely driven by the overuse of antibiotics and misdiagnosis of disease etiology due to the fact that bacterial and viral infections are often clinically indistinguishable.
LIAISON® MeMed BV® is an innovative immune-based protein signature test that measures and computationally integrates the levels of three host-proteins (TRAIL, IP-10 and CRP) to deliver fast, easy-to-interpret results indicating the likelihood of a bacterial or viral infection.
The right test, at the right time, delivers unbiased results you can trust in as little as 35 minutes. LIAISON® MeMed BV® helps to eliminate clinical uncertainty while promoting the appropriate use of antibiotics.
How it works
From a simple serological sample, LIAISON® MeMed BV® automatically measures, analyzes and integrates the levels of three host immune proteins (TRAIL, IP-10 and CRP) into a single and simple score, showing the likelihood of a bacterial immune response or co-infection versus a likely viral immune response..
Three biomarkers +
machine learning =
better patient care
Consolidate your specialty testing onto a LIAISON®, high throughput analyzer
The fully automated LIAISON® MeMed BV® test is part of Diasorin's comprehensive portfolio of immunoassays, allowing laboratories to optimize their workflows while meeting critical emergency department timelines.
35 minutes to results
Fast results give clinicians insights needed in urgent situations.
Results you can trust
LIAISON® MeMed BV® delivers powerful diagnostics, with greater than 99% viral agreement, the clinical performance has been confirmed in validation based on testing with over 20,000 patients.
Why use LIAISON®
MeMed BV®
Quick, objective, diagnostic results to inform treatment decisions.
Pioneering, easy-to-read diagnostic solution
Provides objective, standardized diagnostic results for optimized laboratory workflows.
Meet critical emergency department timelines
Delivers accurate and reliable results to support and reinforce your laboratory's reputation.
High performance, productivity and workflow
Provides a positive cost-benefit to the hospital system.
Empower your lab to address antibiotic misuse
Avoid potential patient adverse side effects, decrease chances and speed of higher community resistance levels, cost savings at the patient level and overall utilization.
To be used on
Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
LIAISON® XS
A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.
Background
To treat or not to treat with antibiotics? Transform patient care with confidence while empowering antimicrobial stewardship
Increased antimicrobial resistance is one of the key healthcare challenges around the world.
Largely driven by the overuse of antibiotics, it often results from the misdiagnosis of disease etiology due to the fact that bacterial and viral infections are often clinically indistinguishable.
LIAISON® MeMed BV® is an innovative immune-based protein signature test that measures and computationally integrates the levels of three host-proteins (TRAIL, IP-10 and CRP) to deliver fast, easy-to-interpret results indicating the likelihood of a bacterial or viral infection.
The right test, at the right time, delivers unbiased results you can trust in as little as 35 minutes. LIAISON® MeMed BV® helps to eliminate clinical uncertainty while promoting the appropriate use of antibiotics.
How it works
From a simple serological sample, LIAISON® MeMed BV® automatically measures, analyzes, and integrates the levels of three host immune proteins (TRAIL, IP-10, and CRP) into a single, easy-to-interpret score, showing the likelihood of a bacterial immune response or co-infection versus a likely viral immune response.
Three biomarkers +
machine learning =
better patient care
35 minutes to results
Save time and streamline clinical decision-making by quickly identifying the etiology of viral and bacterial infections
Optimized treatment path
Effectively reduce treatment delays, unnecessary admissions, exposure to the side effects of antibiotics, and possible readmissions
Empower clinical decision-making
Fast answers for more informed patient care
Why use LIAISON® MeMed BV®
Quick, unbiased results to support better treatment decisions
Bacterial or viral?
Guarantees a high level of accuracy compared to other clinical parameters.
Easy-to-interpret scientific results
A simple numeric score indicates the likelihood of a viral or bacterial/bacterial co-infection which guarantees a high level of accuracy compared to other clinical parameters.
Pioneering diagnostic solution
The targeted test enables more informed decision-making, helping improve the overall quality of patient well-being.
Provides a positive cost-benefit to the hospital system
Faster results, better performance, and streamlined workflow reduce unnecessary patient time spent in the ED by reducing diagnostic uncertainty.
To be used on
Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
LIAISON® XS
A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.